France approves antibody therapy for high-risk Covid cases
PARIS, Dec 11, 2021 (AFP) – French health authorities have approved the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus. The independent public health body HAS Friday night announced “a greenlight for the preventive use of Evusheld… for patients with a very high-risk of contracting a severe form of Covid-19“. … Read more
